| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,200,582 | 1,101,844 | 846,248 | 1,348,139 | | Cost of Revenue | 1,181,260 | 986,690 | 695,773 | 1,461,293 | | | Gross Profit | 19,322 | 115,154 | 150,475 | (113,154) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 13,650 | 12,866 | 12,421 | 11,790 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 18,099 | 17,983 | 18,144 | 17,684 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (12,427) | 84,305 | 119,910 | (142,628) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 661 | 771 | 516 | 734 | | Earnings Before Interest And Taxes | (11,766) | 85,076 | 120,426 | (141,894) | | Interest Expense | 6,709 | 6,917 | 7,420 | 8,087 | | Income Before Tax | (18,475) | 78,159 | 113,006 | (149,981) | | Income Tax Expense | (3,348) | 28,318 | 39,547 | (52,607) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (15,127) | 49,841 | 73,459 | (97,374) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (15,127) | 49,841 | 73,459 | (97,374) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($15,127) | $49,841 | $73,459 | ($97,374) |
|
0.51% Nasdaq 
Income Statement
